Top

Supportive Care in Cancer

Published in:

01-04-2009 | Original Article

Development and validation of the system of quality of life instruments for cancer patients: breast cancer (QLICP-BR)

Authors: Chonghua Wan, Zheng Yang, Xueliang Tang, Tianning Zou, Dedian Chen, Dongmei Zhang, Qiong Meng

Published in: Supportive Care in Cancer | Issue 4/2009

Abstract

Goals

To develop and validate a quality of life (QOL) instrument for patients with breast cancer, QLICP-BR, which is one of the system of QOL instruments for cancer patients in China.

Methods

Using the programmed decision methods of instrument development, the quality of life instrument for cancer patients-breast cancer (QLICP-BR) with considering Chinese cultural background was developed, and evaluated on the data from 186 inpatients with breast cancer. The statistical methods used in this research included statistical description, Pearson correlation, factor analysis, and paired t test.

Results

The test–retest reliability for the overall scale and five domains are all above 0.75. Internal consistency α for each domain is higher than 0.65 except social domain (0.58). Most correlation coefficients between each item and it’s domain are above 0.60. The scores differences between pretreatment and post-treatment for overall scale, general module, physical domain, psychological domain and social domain have statistical significance.

Conclusions

The QLICP-BR is of good validity, reliability, and reasonable responsiveness, and can be used to assess quality of life for patients with breast cancer in China.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef

Anderson JJ, Chernoff MC (1993) Sensitivity to change of rheumatoid arthritis clinical trial outcome measures. J Rheumatol 20:535–537PubMed

Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G (1997) Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 15(3):974–986PubMed

Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed

Hunt SM, Mckznna SP, Mcewen J, Williams J, Papp E (1981) The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med 15:221–229

Husted JA, Cook RJ, Farewell VT, Gladman DD (2000) Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 53:459–468PubMedCrossRef

McGraw KO, Wong SP (1996) Forming inferences about some intraclass correlation coefficients. Psychol Methods 1(1):30–46CrossRef

Norman GR, Stratford P, Regehr G (1997) Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. J Clin Epidemiol 50:869–879PubMedCrossRef

Selby PJ, Champon JA, Etazadi-Amoli J, Dalley D, Boyd NF (1984) The development of a method for assessing the quality of life of cancer patients. Br J Cancer 50(1):13–22PubMed

10.

Schuck P (2004) Assessing reproducibility for interval data in health-related quality of life questionnaires: which coefficient should be used? Qual Life Res 13:571–586PubMedCrossRef

11.

Sprangers MA (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14(10):2756–2768PubMed

12.

Stewart AL, Hays RD, Ware JE Jr (1988) The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 26:724–735PubMedCrossRef

13.

Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PM (2003) On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 12:349–363PubMedCrossRef

14.

The WHOQOL Group (1998) The Word Health Organization Quality of Life assessment (WHOQOL): devolvement and psychometric properties. Soc Sci Med 46(12):1569–1585CrossRef

15.

Wan C, Luo J, Yang Z, Meng Q, Zhang X, Lu Y, Tang X, Zhang C (2007) Development of the general module of the system of quality of life instruments for cancer patients: responsiveness analysis (in Chinese). Chin J Cancer 26(4):337–340

16.

Wan C, Luo J, Zhang C, Tang X, Chen M, Song Y (2003) Study on the system of quality of life instruments for cancer patients (QLICP) (in Chinese). Chin J Behav Med Sci 12(3):341–342

17.

Wan C, Meng Q, Luo J, Tang X, Zhang C, Lu Y, Yang Z, Zhang X (2007) Development of the general module of the system of quality of life instruments for cancer patients: items selection and structure of the general module (in Chinese). Chin J Cancer 26(2):113–117

18.

Wan C, Meng Q, Tang X, Zhang C, Lu Y, Luo J, Yang Z, Zhang X (2007) Development of the general module of the system of quality of life instruments for cancer patients: reliability and validity analysis (in Chinese). Chin J Cancer 26(3):225–229

19.

Wan C, Tang X, Tu X, Feng C, Messing S, Meng Q, Zhang X (2007) Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients. Breast Cancer Res Treat 105(2):187–193PubMedCrossRef

20.

Wan C, Yang Z, Meng Q, Feng C, Wang H, Tang X, Zhang C, Lu Y, Luo J, Zhang X (2008) Development and validation of the general module of the system of quality of life instruments for cancer patients (QLICP-GM). Int J Cancer 122(1):190–196PubMedCrossRef

21.

Wan C, Zhang D, Yang Z, Tu X, Tang W, Feng C, Wang H, Tang X (2007) Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. Breast Cancer Res Treat 106(3):413–418PubMedCrossRef

Title: Development and validation of the system of quality of life instruments for cancer patients: breast cancer (QLICP-BR)
Authors: Chonghua Wan
Zheng Yang
Xueliang Tang
Tianning Zou
Dedian Chen
Dongmei Zhang
Qiong Meng
Publication date: 01-04-2009
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 4/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-008-0478-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Goals

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2009

Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials

Comprehensive analysis of cancer coverage in important Chinese newspapers between 2000 and 2007

Patterns of sore mouth in outpatients with cancer receiving chemotherapy

Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings

Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study

Development and evaluation of a problem-focused psychosocial intervention for patients with head and neck cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer